Lonza wins $7m US NIH stem cell contract

- Last updated on GMT

Related tags: Stem cell

Lonza wins $7m US NIH stem cell contract
Lonza wins $7m US NIH stem cell contract
Lonza has won a second US NIH contract to manufacture stem cells for medical research.

The three-year contract – which is worth around $7m (€5.3m) – will see the Swiss life sciences supply the National Institutes of Health Centre for Regenerative Medicine with clinical grade induced pluripotent stem cells (iPCSs) made at its facility in Walkersville, Maryland in the US.

Lonza won its first stem cell production contract with the NIH in 2012 a few years after founding its Pluripotent Stem Cell Innovation Center which – according to Stephan Kutzer, COO Lonza Pharma-Biotech - has develop the processes needed to manufacture stem cells on a commercial scale.

"First, the group was tasked with developing technologies to help the field move pluripotent stem cell derived therapies to the clinic.  Second, it was tasked with providing a comprehensive service offering to support both basic and clinical PSC research.  This latest NIH contract validates Lonza's investments in this key strategic area."​   

Related topics: Bio Developments, Cell lines

Related news

Show more

Related products

show more

How Viral Safety Testing Will Evolve

How Viral Safety Testing Will Evolve

Viral Safety for mAb: Prevent, Detect, Remove | 20-May-2020 | Event Programme

The pressure to shorten delivery times and reduce costs for biologics are driving an evolution in the biomanufacturing space. Many of the methods used...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Small-Scale Cell Culture Perfusion Process

Small-Scale Cell Culture Perfusion Process

Eppendorf for Bioprocess – Solutions that grow with you | 29-Mar-2019 | Application Note

Perfusion cell culture processes promise advantages for industrial bioprocessing, like saving space, increasing volumetric productivity, achieving more...

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 17-Sep-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

Related suppliers

Follow us

Products

View more

Webinars